Urte Gayko – Biography
Last update: March 30, 2026Executive profile
Urte was Senior Vice President, Drug Development & Regulatory Affairs at Nektar Therapeutics, and Global Head of Regulatory Affairs and Pharmacovigilance at Pharmacyclics.
Urte Gayko is currentlyChief Regulatory Affairs, Quality Assurance & Safety at Summit Therapeutics - View - Summit Therapeutics org chart
Create your alert
to follow the career of Urte Gayko.
Education
Urte Gayko has a PhD in Molecular and Cellular Biology from Harvard University.
They have also studied at Harvard University :
Find more alumni from Harvard University
More about Urte Gayko
Selected links
Do you need to know more about Urte Gayko? More results.
Participate
Social media
- Urte Gayko on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Urte Gayko
The colleagues of Urte Gayko
Company Colleagues
- At Summit Therapeutics, Urte Gayko has 36 colleagues including Bob Duggan (Co-CEO & Chairman), Maky Zanganeh (Co-CEO & Director)…
Industry Colleagues
- In the Biotechnology industry, Urte Gayko has 35,756 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Get in Touch
Here are a few tips for establishing great contacts.
